Here is some other vaccine news of note for the week.
> Merck's Gardasil sales grew 24% in the first quarter to $660 million. Release
> FluGen's CEO said the company will consider seeking funding from a new Gates Foundation universal flu vaccine challenge. Xconomy article
> Rational Vaccines, a company that has come under fire for unregulated vaccine testing, removed a lawsuit to federal court in Illinois. Law360 article
> Pfizer's Prevnar sales slipped 1% to $1.38 billion in the first quarter. Release (PDF)